Serotonin-induced contraction in mesenteric resistance arteries: Signaling and changes in deoxycorticosterone acetate-salt hypertension

Hypertension

Volumn 39, Issue 3, 2002, Pages 825-829

  Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

5 hydroxytryptamine; Deoxycorticosterone; Resistance

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CONTRACTILE PROTEIN; DEOXYCORTICOSTERONE ACETATE; GENISTEIN; KETANSERIN; NIFEDIPINE; PHOSPHOLIPASE C INHIBITOR; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SEROTONIN 1F RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HYPERTENSION; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARBAZOLES; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HYPERTENSION; INDOLES; KETANSERIN; MALE; MESENTERIC ARTERIES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; SUMATRIPTAN; THIOPHENES; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0036199926     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy0302.104668     Document Type: Article

References (34)

1. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats
2. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle
3. Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats
4. Contrasting effects of norepinephrine and 5-hydroxytryptamine on contractility of abdominal aorta of two kidney-two clip hypertensive rats: Effects of inhibitors of arachidonic acid metabolic enzymes
5. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension
6. Evidence that blood pressure reduction by serotonin antagonists is related to α-receptor blockade
7. Serotonin, hypertension and vascular disease
8. Serotoninergic mechanisms in hypertension: Focus on the effects of ketanserin
9. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
10. 2B receptor antagonist LY272015 inhibits 5-HT-induced contraction in the aorta of miueralocorticoid-salt hypertensive rats
11. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension
12. 2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertension
13. 2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats
14. 2B receptor antagonist LY272015 is antihypertensive in DOCA-salt hypertensive rats
15. 2F) from rat stomach fundus
16. 2F receptor
17. Direct upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone actate-salt hypertension by mineralocorticoids
18. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: Modulation of phosphoinositide turnover by phorbol ester
19. 2 receptors mediating contraction in vascular smooth muscle
20. 1B receptor mRNA in blood vessels
21. Vascular receptors for 5-hydroxytryptamine: Distribution, function and classification
22. 1F receptor agonists in human and bovine cerebral arteries: Similarity with human coronary artery
23. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: Lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein
24. Epidermal growth factor: A potent vasoconstrictor in experimental hypertension
25. 1F receptor
26. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling
27. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse
28. 1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine
29. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: Use of the mitogen-activated protein kinase kinase inhibitor PD098059
30. 2A receptor signal transduction
31. 2A receptor activation of the mitogen activated protein kinase pathway in vascular smooth muscle
32. Mechanism of ergonovine-induced contraction in the mesenteric artery from deoxycorticosterone acetate salt hypertensive rat
33. 5-Hydroxytryptamine receptors and effector coupling mechanism in peripheral tissues
34. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine1B receptors in the mesenteric artery of the deoxycorticosterone acetate salt rat